EWING, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today reported operating and financial results for the second quarter ended June 30, 2017. The Company reported revenue of $13.4 million and a net loss per share of $0.02 for the three months ended June 30, 2017.
